Akums launches extended-release tablets for severe morning sickness

Source: Financial Express Akums Drugs and Pharmaceuticals Ltd., a Contract Development and Manufacturing Organization (CDMO), on Wednesday announced the launch of Doxylamine + Pyridoxine extended-release tablets, a therapy approved by the CSDCO (Central Drugs Standard Control Organization), India and the United States Food and Drug Administration (USFDA). The company claims that this marks a milestone […]